Illumina appoints Joydeep Goswami as Interim CFO
Sam Samad will be departing Illumina on July 8, 2022, after serving as CFO for more than five years.
Sam Samad will be departing Illumina on July 8, 2022, after serving as CFO for more than five years.
The single in vitro diagnostic test helps inform therapy decisions according to clinical guidelines to enable precision medicine earlier in the disease journey
In numerous neurological and rare disorders, where clinical characteristics can be confusing, NGS-based approaches have demonstrated considerable increases in disease detection rates over other approaches
Most recently, Rollins was the Chief Information Officer at UnitedHealthcare
First-of-its-kind Incubator will support companies poised to deliver breakthrough applications in genomics and multiomics
It supports sequencing-based COVID 19 surveillance in India
Novel illumination system with key components molded in Radel® PPSU for durability and repeated sterilization
CLL is one of the most common leukemias among adults affecting more than 200,000 people in the US
This exposé embarks on an illuminative journey, unfurling the crucial stratagems imperative for upholding public health, achieved through the unyielding fortress of pharmaceutical quality safeguards
Our collaboration with MediSage to present 'Current Approaches to Uro-Oncology' embodies a crucial stride towards comprehensive cancer care
Subscribe To Our Newsletter & Stay Updated